TRI facility · TRI 2024 reporting year

Mitsubishi Logisnext Americas

Total reported releases 36 lb more than doubled year over year (+107%). Total releases concentrations have more than doubled since 2021.

240 N PROSPECT, Marengo, Illinois · 333924 · Machinery · operated by Mitsubishi Logisnext Americas

TOTAL RELEASES · 20212024
Bar chart of annual values from 2021 to 2024, in lb. Most recent year (2024): 36.36'21'22'23'2436
Anomaly engine

Notable Signals

No notable signals at this facility for the current reporting year. See chemicals and equity context below for the full picture.

Chemicals reported · most recent year

What This Facility Releases

GENERALCAS 7440-50-8

Copper

27 lb · +129% YoY

Copper concentrations have more than doubled since 2022.

CARCINOGENCAS 7440-02-0

Nickel

9 lb · +86% YoY

Nickel concentrations have more than doubled since 2022.

RESPIRATORYCAS 7440-47-3

Chromium

0 lb · -76% YoY

Chromium volumes here are too small to anchor a multi-year trend; YoY movement is still shown above.

Equity context · ACS 2018-2022 block-group demographics

Who Lives Next To This Facility

Within 3 miles of this facility (5 Census block groups, population-weighted demographics): a population of 8,379. Why we surface this →

POPULATION SHARE
25.3%

Low-income

POPULATION SHARE
15.5%

People of color

POPULATION SHARE
7.9%

Under age 5

POPULATION SHARE
13.8%

Over age 64

Source: Census ACS 2018-2022 block-group demographics, population-weighted across the 3-mile buffer around this facility (from USEPA-clone/EJAM-open blockgroupstats). Indicator-level percentile and EJ-disparity scores are surfaced on the county page and the state page — they describe wider regional exposure burdens, not effects attributable to a single facility.

Source. EPA Toxics Release Inventory · retrieved 2026-05-07. Reporting year 2024. TRI is a federal public-domain dataset under 17 USC §105.

What this is not. TRI quantifies releases reported by the facility under EPCRA §313 — not ambient air or water concentrations measured at receptors. We do not attribute individual health outcomes to specific facilities; that exceeds what the data can support.